These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29100654)

  • 1. Do Oxidized Lipoproteins Cause Atherosclerotic Cardiovascular Diseases?
    Arsenault BJ; Bourgeois R; Mathieu P
    Can J Cardiol; 2017 Dec; 33(12):1513-1516. PubMed ID: 29100654
    [No Abstract]   [Full Text] [Related]  

  • 2. Atherosclerosis: cell biology and lipoproteins.
    Wahle KW; Heys SD
    Curr Opin Lipidol; 2008 Aug; 19(4):435-7. PubMed ID: 18607194
    [No Abstract]   [Full Text] [Related]  

  • 3. Oxidized lipoprotein lipids and atherosclerosis.
    Ahotupa M
    Free Radic Res; 2017 Apr; 51(4):439-447. PubMed ID: 28412863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease.
    Rosenson RS; Davidson MH; Hirsh BJ; Kathiresan S; Gaudet D
    J Am Coll Cardiol; 2014 Dec; 64(23):2525-40. PubMed ID: 25500239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoproteins and Cardiovascular Redox Signaling: Role in Atherosclerosis and Coronary Disease.
    Haghikia A; Landmesser U
    Antioxid Redox Signal; 2018 Jul; 29(3):337-352. PubMed ID: 28817963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Front line of oxidized lipoproteins: role of oxidized lipoproteins in atherogenesis and cardiovascular disease risk].
    Yoshida H
    Rinsho Byori; 2010 Jun; 58(6):622-30. PubMed ID: 20662275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingolipids and cardiovascular diseases: lipoprotein metabolism, atherosclerosis and cardiomyopathy.
    Jiang XC; Goldberg IJ; Park TS
    Adv Exp Med Biol; 2011; 721():19-39. PubMed ID: 21910080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current world literature.
    Curr Opin Lipidol; 2011 Aug; 22(4):308-10. PubMed ID: 21743305
    [No Abstract]   [Full Text] [Related]  

  • 9. New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease.
    Tsimikas S; Tsironis LD; Tselepis AD
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2094-9. PubMed ID: 17626905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein oxidation in cardiovascular disease: chief culprit or innocent bystander?
    Heinecke JW
    J Exp Med; 2006 Apr; 203(4):813-6. PubMed ID: 16606677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research digest: next-generation lipoprotein therapeutics.
    Berberich AJ; Hegele RA
    Lancet Diabetes Endocrinol; 2020 Mar; 8(3):190. PubMed ID: 32085826
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current problems in mutual relations of cerebral vascular and cardiovascular diseases in elderly and senile age].
    Borovkova TA; Miakotnykh VS
    Adv Gerontol; 2010; 23(3):409-20. PubMed ID: 21137213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atherosclerotic risk factors in cardiovascular disease.
    LaRosa JC
    J Reprod Med; 1986 Sep; 31(9 Suppl):906-12. PubMed ID: 3772910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered lipoproteins in patients with systemic lupus erythematosus are associated with augmented oxidative stress: a potential role in atherosclerosis.
    Park JK; Kim JY; Moon JY; Ahn EY; Lee EY; Lee EB; Cho KH; Song YW
    Arthritis Res Ther; 2016 Dec; 18(1):306. PubMed ID: 28038677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From pathophysiology to targeted therapy for atherothrombosis: a role for the combination of statin and aspirin in secondary prevention.
    Chapman MJ
    Pharmacol Ther; 2007 Jan; 113(1):184-96. PubMed ID: 17070923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins and foam cell formation: impact on LDL oxidation and uptake of oxidized lipoproteins via scavenger receptors.
    Hofnagel O; Luechtenborg B; Weissen-Plenz G; Robenek H
    Biochim Biophys Acta; 2007 Sep; 1771(9):1117-24. PubMed ID: 17690011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Green tea and heart health.
    Naito Y; Yoshikawa T
    J Cardiovasc Pharmacol; 2009 Nov; 54(5):385-90. PubMed ID: 19668087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative modification of lipoproteins.
    Arai H
    Subcell Biochem; 2014; 77():103-14. PubMed ID: 24374922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Indicators of oxidative stress in cardiovascular diseases. I. Lipoperoxidation].
    Racek J; Holecek V; Trefil L
    Vnitr Lek; 1999 Jun; 45(6):367-72. PubMed ID: 11045174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk?
    Verhoye E; Langlois MR;
    Clin Chem Lab Med; 2009; 47(2):128-37. PubMed ID: 19099526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.